Nuclear targeting peptide-modified, DOX-loaded, PHBV nanoparticles enhance drug efficacy by targeting to Saos-2 cell nuclear membranes

Sahin A., Eke G., Buyuksungur A., HASIRCI N., Hasirci V.

Journal of Biomaterials Science, Polymer Edition, cilt.29, sa.5, ss.507-519, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1080/09205063.2018.1423812
  • Dergi Adı: Journal of Biomaterials Science, Polymer Edition
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.507-519
  • Anahtar Kelimeler: PHBV, biodegradable nanoparticles, nuclear drug delivery, doxorubicin, nuclear localization signal, PLGA NANOPARTICLES, POLY(LACTIDE-CO-GLYCOLIDE) NANOPARTICLES, DOXORUBICIN DELIVERY, CANCER-THERAPY, DISTINCT MODES, TUMOR-CELLS, APOPTOSIS, NANOTECHNOLOGY, MICRO/NANOPARTICLES, RELEASE
  • Ankara Üniversitesi Adresli: Hayır

Özet

© 2018 Informa UK Limited, trading as Taylor & Francis Group.The aim of this study was to target nano sized (266 ± 25 nm diameter) poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) particles carrying Doxorubicin (DOX), an anticancer agent, to human osteosarcoma cells (Saos-2). A nuclear targeting molecule (Nuclear Localization Signal, NLS), a 17 a.a. peptide, was attached onto the doxorubicin loaded nanoparticles. NLS conjugated nanoparticles surrounded the cell nuclei, but did not penetrate them. Free doxorubicin and doxorubicin loaded nanoparticles entered the cytoplasm and were evenly distributed within the cytoplasm. The localization of the NLS-targeted particles around the nuclear membrane caused a significantly higher decrease in the cancer cell numbers due to apoptosis or necrosis than the untargeted and free doxorubicin formulations showing the importance of targeting the nanoparticles to the nuclear membrane in the treatment of cancer.